During the development of cancer a series of specific genetic alterations have to occur in a stepwise fashion to transform a normal somatic cell into a malignant tumor cell. These genetic changes can be roughly divided in two groups: mutations in proto-oncogenes that result in a constantly activated
Validation studies with Muta™ mouse: A transgenic mouse model for detecting mutations in vivo
✍ Scribed by Brian C. Myhr
- Book ID
- 102835143
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 609 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0893-6692
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The in-vivo somatic mutation method developed by us in an earlier X-ray experiment was tested for its usefulness in chemical mutagenesis work, specifically in the prescreening for germinal point mutations. In order to explore possible parallelisms, the 7 compounds chosen for study, as well as the ge
## Abstract The present work describes the use of the infant (4‐wk‐old) mouse as an animal model for the study of DNA damage–induced G~1~ checkpoint response, changes in p53 protein levels, and multiple gene expression changes after DNA damage has been induced in the liver. Hepatocytes in the infan
A tk+/mouse embryonic stem (ES) cell line, designated 1G2, has been created in which one allele of the thymidine kinase (tk) gene was inactivated by targeted homologous recombination. This line is an analog of the mouse lymphoma tk+/-L5 178Y cell line, which is used widely to assess the mutagenicity